These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12717971)

  • 1. [Antibiotic resistant Pseudomonas aeruginosa].
    Gotoh N
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():196-201. PubMed ID: 12717971
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antimicrobial drug therapy and microbial sensitivity tests: general concept of antibiotics].
    Miyazakin S; Yamaguchi K
    Rinsho Byori; 1997 Jul; Suppl 105():162-73. PubMed ID: 9379536
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa.
    Bonomo RA; Szabo D
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S49-56. PubMed ID: 16894515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms of resistance in Pseudomonas aeruginosa].
    Cercenado Mansilla E; García Garrote F
    Rev Clin Esp; 1998 Sep; 198 Suppl 2():10-6. PubMed ID: 9844472
    [No Abstract]   [Full Text] [Related]  

  • 5. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.
    Maniati M; Ikonomidis A; Mantzana P; Daponte A; Maniatis AN; Pournaras S
    J Antimicrob Chemother; 2007 Jul; 60(1):132-5. PubMed ID: 17483142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of multiresistant serotype 012 Pseudomonas aeruginosa to fosfomycin in combination with other antibiotics.
    Watine J; Bourrel C; Dubourdieu B; Gineston JL; Bories P; Durand M; Marre A; Formosa F; Brunel MP; Palliez J
    Pathol Biol (Paris); 1994 Apr; 42(4):293-5. PubMed ID: 7808781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multiply resistant Pseudomonas aeruginosa in the pediatric field].
    Tabuki K
    Nihon Rinsho; 1991 Oct; 49(10):2387-92. PubMed ID: 1660948
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fluoroquinolone and aminoglycoside resistance in chromosomal cephalosporinase-overproducing gram-negative bacilli strains with inducible beta-lactamase].
    López-Yeste M; Xercavins M; Lite J; Cuchí E; Garau J
    Enferm Infecc Microbiol Clin; 1996 Apr; 14(4):211-4. PubMed ID: 9044634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanisms of pandrug-resistance of Pseudomonas aeruginosa].
    Shen JL; Zhu DM; Wang MG
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1859-62. PubMed ID: 19040025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biochemical and genetical mechanisms in emergence of multidrug-resistant Pseudomonas aeruginosa (MDRP)].
    Noguchi K; Gotoh N
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():457-62. PubMed ID: 17455662
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of resistance of Pseudomonas aeruginosa isolates to select antibiotics].
    Sekowska A; Janicka G; Wojda M; Wróblewska J; Manysiak S
    Pol Merkur Lekarski; 2005 Aug; 19(110):169-71. PubMed ID: 16245425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interpretive reading of the non-fermenting gram-negative bacilli antibiogram].
    Vila J; Marco F
    Enferm Infecc Microbiol Clin; 2010 Dec; 28(10):726-36. PubMed ID: 20579775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals.
    Wang J; Zhou JY; Qu TT; Shen P; Wei ZQ; Yu YS; Li LJ
    Int J Antimicrob Agents; 2010 May; 35(5):486-91. PubMed ID: 20185276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of efflux pumps to high level resistance of Pseudomonas aeruginosa to ciprofloxacin.
    Wang DD; Sun TY; Hu YJ
    Chin Med J (Engl); 2007 Jan; 120(1):68-70. PubMed ID: 17254491
    [No Abstract]   [Full Text] [Related]  

  • 15. Efflux system overexpression and decreased OprD contribute to the carbapenem heterogeneity in Pseudomonas aeruginosa.
    Ikonomidis A; Tsakris A; Kantzanou M; Spanakis N; Maniatis AN; Pournaras S
    FEMS Microbiol Lett; 2008 Feb; 279(1):36-9. PubMed ID: 18070070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
    Hocquet D; Muller A; Blanc K; Plésiat P; Talon D; Monnet DL; Bertrand X
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1173-5. PubMed ID: 18180356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
    El Amin N; Giske CG; Jalal S; Keijser B; Kronvall G; Wretlind B
    APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A carbapenem-susceptible Pseudomonas aeruginosa strain carrying the bla(SPM) gene.
    Pellegrino FL; Casali N; Nouér SA; Riley LW; Moreira BM
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):214-6. PubMed ID: 18308497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of mex-gene products in antibiotic extrusion in Pseudomonas aeruginosa.
    Yoneyama H; Ocaktan A; Tsuda M; Nakae T
    Biochem Biophys Res Commun; 1997 Apr; 233(3):611-8. PubMed ID: 9168899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin.
    Hocquet D; Roussel-Delvallez M; Cavallo JD; Plésiat P
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1582-3. PubMed ID: 17220417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.